Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) I trial
Introduction Biannual (ie, every 6 months) mass drug administration of azithromycin has reduced childhood mortality in Niger, but its effects on specific respiratory pathogens are not fully elucidated.Methods Across 2 years of the Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistanc...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/10/2/e016043.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|